TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
IPSC

Century Therapeutics Inc

Healthcare · Biotechnology

1.70$ -1.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement IPSC
Line item 2015 2016 2019 2020 2021 2022 2023 2024 2025
– -50.5% -100.0% – – +391.4% -57.0% +194.8% +1,556.8%
– -47.4% -99.9% +604.4% +161.2% +119.8% +29.5% +2.0% -1.5%
– -96.0% -110.0% – – – -57.0% +194.8% +1,357.9%
– -20.5% +56.9% +178.2% +90.6% +28.5% -4.6% +15.7% -10.8%
– -25.2% -92.9% +64.6% +102.6% +65.6% +8.9% -4.5% -27.6%
– – – +139.7% +90.4% +54.0% +7.0% -2.7% -23.2%
– – – – – – – – –
– – – – +234.6% -13.3% -51.1% -100.0% –
– – – – – – – – –
– – – -10.3% -96.0% +111.6% +1,967.0% -4.8% -103.8%
– – – – – – – – –
– – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?